When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia
CME
1
|
MOC
1
|
Nursing
1
When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia

AACE Rare Diseases and Hormone Disorders Webinar Series is pleased to present When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia. This webinar is designed to help clinicians create a path to diagnosis when encountering a patient with severe hypertriglyceridemia (SHTG).

This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest clinical guidance and educational resources for diagnosing, managing, and treating SHTG. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.

When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia will be held on Friday, October 31 at 11:00 AM EDT – 12:00 PM EDT.

View All AACE Rare Diseases and Hormone Disorders Webinars

Managing TED in Practice: Expanding the Endocrinologist’s Scope
Paresthesias Muscle Spasms and Cramps – Unraveling the Hypocalcemia Puzzle in Hypoparathyroidism
Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment
Cortisol Deficiency and Androgen Excess: Navigating the Challenges of CAH
Coming soon: Polycystic Ovary Syndrome
Register
1
CME
Starts

10/31/2025

Expires

10/03/2026

Learning Objectives

Upon completion of the program, participants will be able to:

  • Describe the diagnostic and testing approach in evaluating a patient with severe hypertriglyceridemia.
  • Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat severe hypertriglyceridemia.
  • Identify and treat long-term complications and comorbidities of severe hypertriglyceridemia.
Target Audience

Endocrinologists are the primary target audience; however, all healthcare professionals including primary care physicians, nurse practitioners, nurses, physician associates and endocrine care professionals who treat patients with rare endocrine diseases in their practice may also access this program.

Speakers/Faculty

SPEAKER
FACULTY

Robert H. Eckel, MD
Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism & Diabetes
Division of Cardiology
S/P Professor of Physiology & Biophysics
S/P Charles A. Boettcher II Chair in Atherosclerosis
University of Colorado Anschutz Medical Campus
Past President, North American Association for the Study of Obesity (AKA The Obesity Society)
Past President, American Heart Association
Past President Medicine and Science, American Diabetes Association

Commercial Support

This activity is supported by an independent educational grant from Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals.